Eve Mylchreest
About Eve Mylchreest
Eve Mylchreest is the Scientific Senior Director at Bristol Myers Squibb in New Brunswick, New Jersey, with over 25 years of experience in toxicology and biochemistry.
Company
Eve Mylchreest is currently employed at Bristol Myers Squibb in New Brunswick, New Jersey, United States. She holds the position of Scientific Senior Director at the company. Bristol Myers Squibb is a prominent global biopharmaceutical company known for developing innovative medicines to address serious diseases including cancer, cardiovascular disease, and immune-inflammatory conditions.
Title
Eve Mylchreest serves as the Scientific Senior Director at Bristol Myers Squibb. In this role, she oversees scientific research and development initiatives, focusing on improving therapeutic outcomes through advanced scientific methodologies. Her position entails leadership in scientific strategy, contributing to the company’s mission to discover and deliver groundbreaking treatments.
Education and Expertise
Eve Mylchreest has an extensive background in toxicology and biochemistry, having earned multiple degrees from Université de Montréal. She holds a Doctor of Philosophy (Ph.D.) in Toxicology, completed between 1994 and 1997, a Master’s Degree in Toxicology from 1992 to 1994, and a Bachelor’s Degree in Biochemistry, completed from 1985 to 1988. Her academic training laid a strong foundation for her over 25-year career in toxicology, marked by a focus on both applied and mechanistic research.
Professional Background
Eve Mylchreest has held several key positions throughout her career. She worked at Battelle as a Research Leader from 2015 to 2021 in West Jefferson, Ohio, where she led a team pioneering innovative toxicology research methodologies. From 2010 to 2015, she served as Program Leader, Reproductive Toxicology at Southern Research in Birmingham, Alabama, contributing to numerous peer-reviewed publications. At Pfizer (Legacy Wyeth), she was Principal Research Scientist II from 2007 to 2010 in Chazy, New York, focusing on drug safety evaluation. Prior to that, she was Senior Research Toxicologist at DuPont from 1999 to 2007 in Newark, Delaware, where she developed new toxicological assessment protocols. Early in her career, she completed a postdoctoral fellowship at the Chemical Industry Institute of Toxicology from 1996 to 1999 in Research Triangle Park, North Carolina.
Achievements
Eve Mylchreest has made significant contributions to the field of toxicology over her career. While at DuPont, she developed and implemented new toxicological assessment protocols that improved the accuracy of chemical safety evaluations. At Pfizer, her work played a key role in advancing toxicology research in the area of drug safety evaluation. As Program Leader at Southern Research, she contributed to multiple peer-reviewed publications in reproductive toxicology. At Battelle, she led a team focused on developing innovative research methodologies. Her postdoctoral work at the Chemical Industry Institute of Toxicology specialized in mechanistic toxicology research, providing deep insights into toxicological mechanisms.